ACADIA Pharmaceuticals Inc. | Key People and Executives
Stephen R. Biggar
Chairman
Stephen R. Davis
President, Chief Executive Officer & Director
Julian Charles Baker
Director
Edmund P. Harrigan
Independent Director
Daniel B. Soland
Independent Director
Laura A. Brege
Independent Director
Stephen R. Biggar
Chairman
Stephen R. Davis
President, Chief Executive Officer & Director
Todd S. Young
Executive VP, Chief Financial & Accounting Officer
Srdjan R. Stankovic
Executive VP, Head-Research & Development
Randall Owen
Chief Medical Officer & SVP-Clinical Development
Bob Mischler
Senior VP-Strategy & Technology Operations
Michael J. Yang
Chief Commercial Officer & Executive VP
Julian Charles Baker
Director
Elena H. Ridloff
Senior Vice President-Investor Relations
Lisa Barthelemy
Senior Director-Investor Relations
Austin D. Kim
Secretary, Executive VP & General Counsel
Daryl DeKarske
Senior VP & Head-Global Regulatory Affairs
Edmund P. Harrigan
Independent Director
Daniel B. Soland
Independent Director
Laura A. Brege
Independent Director
| Address |
3611 Valley Centre Drive
San Diego California 92130
United States
|
|
Employees
|
- |
| Website |
http://www.acadia-pharm.com |
| Updated |
07/08/2019 |
| ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. The company was founded by Mark R. |
